Dabomb Protein Cash Flow-to-Debt Ratio
Dabomb Protein cash flow-to-debt ratio. Dabomb Protein (6578) has a Cash Flow-to-Debt Ratio of 0.00x as of December 2025, meaning its operating cash flow of NT$-354.00K could theoretically repay 0% of its total liabilities (NT$106.48 Million) in one year. Check Dabomb Protein investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Dabomb Protein (2015–2025)
Cash flow-to-debt ratio of Dabomb Protein from 2015 to 2025. Historical debt coverage capacity for Dabomb Protein across 11 annual periods. Check Dabomb Protein cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Dabomb Protein Cash Flow-to-Debt Ratio by Year (2015–2025)
Dabomb Protein cash flow-to-debt ratio by year from 2015 to 2025. Year-by-year debt coverage analysis for Dabomb Protein. For the full cash flow conversion analysis, see Dabomb Protein cash flow conversion.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.16x | NT$16.65 Million | NT$106.48 Million | ▼ -25.7% |
| 2024 | 0.21x | NT$47.55 Million | NT$225.96 Million | ▲ +1335.7% |
| 2023 | 0.01x | NT$6.51 Million | NT$443.83 Million | ▼ -58.9% |
| 2022 | 0.04x | NT$19.71 Million | NT$552.88 Million | ▲ +153.3% |
| 2021 | -0.07x | NT$-44.25 Million | NT$662.24 Million | ▼ -277.7% |
| 2020 | 0.04x | NT$13.41 Million | NT$356.66 Million | ▼ -75.0% |
| 2019 | 0.15x | NT$33.26 Million | NT$220.96 Million | ▼ -10.4% |
| 2018 | 0.17x | NT$22.07 Million | NT$131.39 Million | ▼ -12.6% |
| 2017 | 0.19x | NT$43.87 Million | NT$228.29 Million | ▼ -35.5% |
| 2016 | 0.30x | NT$59.58 Million | NT$200.11 Million | ▼ -70.8% |
| 2015 | 1.02x | NT$139.78 Million | NT$137.31 Million | — |